| Authors: |
Chenu E; MMV Medicines for Malaria Venture, Meyrin, Switzerland., Duffy J; MMV Medicines for Malaria Venture, Meyrin, Switzerland., Forkuo AD; Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana., Gbedema SY; Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana., Abdelall S; School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Wahajuddin M; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Jones HS; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Wright CW; School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK. |